PT2257534E - Antagonistas 3-aminoalquil-1,4-diazepan-2-ona do recetor 5 da melanocortina - Google Patents
Antagonistas 3-aminoalquil-1,4-diazepan-2-ona do recetor 5 da melanocortina Download PDFInfo
- Publication number
- PT2257534E PT2257534E PT97161558T PT09716155T PT2257534E PT 2257534 E PT2257534 E PT 2257534E PT 97161558 T PT97161558 T PT 97161558T PT 09716155 T PT09716155 T PT 09716155T PT 2257534 E PT2257534 E PT 2257534E
- Authority
- PT
- Portugal
- Prior art keywords
- diazepan
- melanocortin
- aminoalkyl
- receptor antagonists
- antagonists
- Prior art date
Links
- 102000030612 Melanocortin 5 receptor Human genes 0.000 title 1
- 108010088565 Melanocortin 5 receptor Proteins 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Pulmonology (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3289408P | 2008-02-29 | 2008-02-29 | |
| US12/391,720 US8008291B2 (en) | 2008-02-29 | 2009-02-24 | 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2257534E true PT2257534E (pt) | 2014-02-17 |
Family
ID=41015440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97161558T PT2257534E (pt) | 2008-02-29 | 2009-02-27 | Antagonistas 3-aminoalquil-1,4-diazepan-2-ona do recetor 5 da melanocortina |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8008291B2 (enExample) |
| EP (1) | EP2257534B1 (enExample) |
| JP (1) | JP5503557B2 (enExample) |
| KR (1) | KR101620114B1 (enExample) |
| CN (1) | CN102007105B (enExample) |
| AU (1) | AU2009219106B2 (enExample) |
| BR (1) | BRPI0907903B1 (enExample) |
| CA (1) | CA2716250C (enExample) |
| DK (1) | DK2257534T3 (enExample) |
| ES (1) | ES2445456T3 (enExample) |
| IL (1) | IL207700A (enExample) |
| MX (1) | MX2010009487A (enExample) |
| NZ (1) | NZ587363A (enExample) |
| PT (1) | PT2257534E (enExample) |
| RU (1) | RU2530017C2 (enExample) |
| WO (1) | WO2009105823A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009219107B2 (en) * | 2008-02-29 | 2013-11-21 | Marp Therapeutics Pty Ltd | Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor |
| WO2010096853A1 (en) * | 2009-02-27 | 2010-09-02 | Mimetica Pty Ltd | Methods of modulating the activity of the mc1 receptor and treatment of conditions related to this receptor |
| CN109956947A (zh) * | 2017-12-25 | 2019-07-02 | 江苏恒瑞医药股份有限公司 | 一种cns抑制剂的新晶型、制备方法及用途 |
| CN115381955B (zh) * | 2021-05-24 | 2024-05-17 | 中国科学技术大学 | 黑皮质素受体mc5r的用途 |
| KR102703324B1 (ko) * | 2022-11-08 | 2024-09-06 | 국민대학교산학협력단 | 아미노벤즈이미다졸 유도체 및 이의 제조방법 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ254752A (en) * | 1992-08-21 | 1997-06-24 | Wa Pharma Ab | Dna fragments encoding melanocyte stimulating hormone receptors, their use in production of encoded polypeptides and diagnostic and therapeutic methods |
| US5622860A (en) * | 1994-02-17 | 1997-04-22 | The Regents Of The University Of Michigan | Genes encoding melanocortin receptors |
| CA2210349A1 (en) | 1995-01-20 | 1996-07-25 | Molecumetics, Ltd | Conformationally constrained reverse-turn library and methods relating thereto |
| US5929237A (en) | 1995-10-27 | 1999-07-27 | Molecumetics Ltd. | Reverse-turn mimetics and methods relating thereto |
| WO1998049186A1 (en) | 1997-04-25 | 1998-11-05 | The Regents Of The University Of California | Dipeptide surrogates containing asparagine-derived tetrahydropyrimidinones |
| AUPP254898A0 (en) | 1998-03-24 | 1998-04-23 | University Of Queensland, The | Peptide turn mimetics |
| AU742747B2 (en) | 1998-03-24 | 2002-01-10 | Mimetica Pty Ltd | Peptide turn mimetics |
| US6645738B1 (en) * | 1998-11-09 | 2003-11-11 | Merck & Co., Inc. | DNA molecules encoding the melanocortin 5 receptor protein from rhesus monkey |
| DE60114413T2 (de) * | 2000-05-25 | 2006-07-27 | F. Hoffmann-La Roche Ag | Substituierte 1-aminoalkyl-lactame und deren verwendung als muscarinrezeptor-antagonisten |
| WO2003013571A1 (en) | 2001-08-10 | 2003-02-20 | Palatin Technologies, Inc. | Peptidomimetics of biologically active metallopeptides |
| US20030110518A1 (en) * | 2001-09-28 | 2003-06-12 | Houseknecht Karen L. | Melanocortin-5 receptor sequences and uses thereof |
| US6916812B2 (en) * | 2001-10-09 | 2005-07-12 | Bristol-Myers Squibb Company | Alpha-aminoamide derivatives as melanocortin agonists |
| EP1446394B1 (en) * | 2001-11-08 | 2006-11-02 | Ortho-McNeil Pharmaceutical, Inc. | Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| US7319107B2 (en) | 2001-11-08 | 2008-01-15 | Johnson & Johnson Consumer Companies, Inc. | 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| WO2003068738A1 (en) | 2002-02-11 | 2003-08-21 | Neurocrine Biosciences, Inc. | Pyrrole derivatives as ligands of melanocortin receptors |
| RU2006101541A (ru) * | 2003-06-20 | 2006-06-10 | Амген Инк. (US) | Производные пиперазина и способ их применения |
| US7281642B2 (en) * | 2004-09-16 | 2007-10-16 | Prime Time Toys, Ltd. | Squirting toy |
| WO2008017852A1 (en) | 2006-08-11 | 2008-02-14 | Palatin Technologies, Inc. | Diamine-containing, tetra- substituted piperazine compounds as melanocortin receptor modulators |
| AU2009219107B2 (en) * | 2008-02-29 | 2013-11-21 | Marp Therapeutics Pty Ltd | Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor |
-
2009
- 2009-02-24 US US12/391,720 patent/US8008291B2/en active Active
- 2009-02-27 CA CA2716250A patent/CA2716250C/en active Active
- 2009-02-27 MX MX2010009487A patent/MX2010009487A/es active IP Right Grant
- 2009-02-27 WO PCT/AU2009/000230 patent/WO2009105823A1/en not_active Ceased
- 2009-02-27 JP JP2010547917A patent/JP5503557B2/ja not_active Expired - Fee Related
- 2009-02-27 EP EP09716155.8A patent/EP2257534B1/en not_active Not-in-force
- 2009-02-27 DK DK09716155.8T patent/DK2257534T3/da active
- 2009-02-27 NZ NZ587363A patent/NZ587363A/en not_active IP Right Cessation
- 2009-02-27 PT PT97161558T patent/PT2257534E/pt unknown
- 2009-02-27 CN CN200980112982.0A patent/CN102007105B/zh not_active Expired - Fee Related
- 2009-02-27 BR BRPI0907903-3A patent/BRPI0907903B1/pt not_active IP Right Cessation
- 2009-02-27 RU RU2010137034/04A patent/RU2530017C2/ru active
- 2009-02-27 KR KR1020107021383A patent/KR101620114B1/ko not_active Expired - Fee Related
- 2009-02-27 AU AU2009219106A patent/AU2009219106B2/en not_active Ceased
- 2009-02-27 ES ES09716155.8T patent/ES2445456T3/es active Active
-
2010
- 2010-08-19 IL IL207700A patent/IL207700A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| KR101620114B1 (ko) | 2016-05-12 |
| RU2010137034A (ru) | 2012-04-10 |
| IL207700A0 (en) | 2010-12-30 |
| JP5503557B2 (ja) | 2014-05-28 |
| BRPI0907903B1 (pt) | 2021-11-09 |
| KR20100122102A (ko) | 2010-11-19 |
| NZ587363A (en) | 2012-06-29 |
| MX2010009487A (es) | 2011-03-02 |
| US8008291B2 (en) | 2011-08-30 |
| CN102007105A (zh) | 2011-04-06 |
| AU2009219106B2 (en) | 2013-09-26 |
| HK1148730A1 (en) | 2011-09-16 |
| IL207700A (en) | 2017-01-31 |
| WO2009105823A1 (en) | 2009-09-03 |
| AU2009219106A1 (en) | 2009-09-03 |
| EP2257534A4 (en) | 2011-05-04 |
| BRPI0907903A2 (pt) | 2020-08-18 |
| DK2257534T3 (da) | 2014-02-03 |
| JP2011513244A (ja) | 2011-04-28 |
| ES2445456T3 (es) | 2014-03-03 |
| CN102007105B (zh) | 2014-09-03 |
| RU2530017C2 (ru) | 2014-10-10 |
| CA2716250A1 (en) | 2009-09-03 |
| CA2716250C (en) | 2016-02-16 |
| EP2257534B1 (en) | 2013-11-06 |
| EP2257534A1 (en) | 2010-12-08 |
| US20090221557A1 (en) | 2009-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201001597B (en) | Octahydropentalene compounds as chemokine receptor antagonists | |
| ZA201103156B (en) | Isonicotinamide orexin receptor antagonists | |
| ZA201203452B (en) | Cgrp receptor antagonists | |
| EP2099454A4 (en) | AMINOPYRROLIDINES AS CHEMOKINE RECEPTOR ANTAGONISTS | |
| ZA200906812B (en) | Crig antagonists | |
| EP2184278A4 (en) | P2X4 RECEIVER ANTAGONIST | |
| IL212551A0 (en) | Cxcr4 receptor compounds | |
| IL212545A0 (en) | Toll-like receptor 3 antagonists | |
| EP2312947A4 (en) | TRPV4 Antagonist | |
| IL204928A0 (en) | Cgrp antagonists | |
| PT2799428T (pt) | Antagonistas de glicagina | |
| EP2010180A4 (en) | IL-8 RECEPTOR ANTAGONISTS | |
| LT2421888T (lt) | Clever-1 receptorių antagonistai, skirti blokuoti imunitetą slopinančius 2 tipo makrofagus | |
| ZA201108724B (en) | Toll-like receptor 3 antagonists | |
| IL207700A0 (en) | 3-aminoalkyl-1,4-diazepan-2-one melanocortin -5 receptor antagonists | |
| AP2010005512A0 (en) | Novel compounds active as muscarinic receptor antagonists. | |
| EP2222676A4 (en) | A1-adenosine receptor antagonistic | |
| EP2161994A4 (en) | UROTENSIN-II Receptor Antagonists | |
| IL207701A0 (en) | 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists | |
| ZA201202150B (en) | [1,4]-benzodiazepines as vasopressin v2 receptor antagonists | |
| IL207438A0 (en) | 2-aminoquinolines as 5-ht5a receptor antagonists | |
| GB0701632D0 (en) | MET receptor antagonists | |
| HK1155164A (en) | Sphingosine-1-phosphate receptor antagonists | |
| ZA201103984B (en) | Toll-like receptor 3 antagonists | |
| GB0916792D0 (en) | (1,4)-Benzodiazepines as vasopressin V2 receptor antagonists |